Overview

Study of Micafungin in Patients With Invasive Candidiasis or Candidemia

Status:
Completed
Trial end date:
2006-04-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of the study is to determine the safety and effectiveness of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or candidemia.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Antifungal Agents
Caspofungin
Echinocandins
Micafungin
Miconazole
Criteria
Inclusion Criteria:

- Patients must have candidemia or invasive candidiasis.

Exclusion Criteria:

- Patients who have received an echinocandin within one month prior to study entry.

- Patients who have received more than two days of prior systemic antifungal therapy for
the current infection.